Market Access Heard on the pipeline: Access to medications Solving the challenge of access to medication has fuelled many a debate among healthcare stakeholders over the years.
Market Access Mind the gap: What is causing the ongoing ADHD drug shortage... Since late 2022, medications for Attention Deficit/Hyperactivity Disorder, or ADHD, have been in a shortage in the United States and the UK.
Market Access Integrating market access considerations into biopharmaceuti... The biopharmaceutical industry operates at the intersection of health innovation and market viability, where the significance of integrating market access insights into investment decisions
Market Access Overcoming AMR market failure: Three start-up stories Slowly but surely, the world’s antibiotics are becoming less effective as disease-causing bacteria evolve into drug-resistant “superbugs”.
News Third Rock in $2bn drug-hunting pact with China's Funnel New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
